These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 9262379)

  • 41. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
    Cheng Z; Nolan AM; McKellar QA
    Inflammation; 1998 Aug; 22(4):353-66. PubMed ID: 9675607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
    Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
    Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of endogenous eicosanoids in rabbit-intraocular inflammation.
    Kulkarni PS
    J Ocul Pharmacol; 1991; 7(3):227-41. PubMed ID: 1664445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.
    Bailey PJ; Dallob AL; Allison DL; Anderson RL; Bach T; Durette PL; Hand KM; Hopple SL; Luell S; Meurer R
    Arzneimittelforschung; 1988 Mar; 38(3):372-8. PubMed ID: 3132928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: Physiological and biochemical studies in murine inflammatory models.
    Jacobson PB; Jacobs RS
    J Pharmacol Exp Ther; 1992 Aug; 262(2):866-73. PubMed ID: 1501127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effects of cyclooxygenase and lipoxygenase inhibitors: the prerequisites for more effective anti-inflammatory combinations].
    Vlaskovska M
    Eksp Med Morfol; 1990; 29(1):44-53. PubMed ID: 2118852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve.
    Le Filliatre G; Sayah S; Latournerie V; Renaud JF; Finet M; Hanf R
    Br J Pharmacol; 2001 Apr; 132(7):1581-9. PubMed ID: 11264253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
    Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
    Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
    Nickerson-Nutter CL; Medvedeff ED
    Arthritis Rheum; 1996 Mar; 39(3):515-21. PubMed ID: 8607901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of a 5-lipoxygenase inhibitor, Sch 40120, on acute inflammatory responses.
    Smith SR; Watnick AW; Bryant RW; Billah M; Siegel MI
    J Pharmacol Exp Ther; 1992 Aug; 262(2):721-8. PubMed ID: 1386887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
    Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW
    J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo.
    von Aulock S; Hermann C; Hartung T
    J Immunol Methods; 2003 Jun; 277(1-2):53-63. PubMed ID: 12799039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors.
    Jiang B; Zeng Y; Li MJ; Xu JY; Zhang YN; Wang QJ; Sun NY; Lu T; Wu XM
    Arch Pharm (Weinheim); 2010 Sep; 343(9):500-8. PubMed ID: 20842641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of eicosanoids in inflammatory reactions of rats.
    Hirschelmann R; Zarnack S; Funke T; Schmidt K; Bekemeier H; Giessler AJ; Ulbricht H
    Biomed Biochim Acta; 1988; 47(10-11):S316-9. PubMed ID: 3150274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of 4-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-2,6-dimethyl-phenol (KR-33749) as an inhibitor of 5-lipoxygenase with potent antiinflammatory activity.
    Cho YS; Kim CH; Surh JH; Kang NS; Yoo SE; Cheon HG
    Pharmacology; 2010; 86(2):65-72. PubMed ID: 20639685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
    Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
    J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.